Hong Kong – December 11, 2024 – (SeaPRwire) – Recently, BOM Network is proud to unveil its solutions to tokenize a wide range of real-world assets, from real estate to commodities, and use these tokens for trading, lending, or as collateral.
Real-World Assets (RWA): The Bridge Between Traditional Finance and Blockchain Revolution
In recent years, the crypto market has undergone remarkable growth, but its volatility and limited real-world use cases have often raised concerns. Real-World Assets (RWA) are emerging as a pivotal trend that may fundamentally reshape the blockchain and crypto space by creating a more stable and tangible connection to traditional finance. The tokenization of RWAs allows for real estate, commodities, and other physical assets to be represented on the blockchain, unlocking liquidity and expanding investment opportunities.RWAs bridge the gap between traditional assets and decentralized finance (DeFi), bringing stability, security, and trust into the often volatile crypto markets. This fusion offers several key benefits:
Access to Illiquid Assets
Increased Liquidity and Market Efficiency
Global Access
The Future of Banking and RWA Integration
BOM Network is one standout project in the RWA space, focusing on integrating blockchain with traditional financial services. BOM Network’s unique approach lies in its emphasis on combining traditional banking services with the efficiency of blockchain, making it an attractive solution for institutions looking to bridge the gap between old and new financial systems.
BOM Network has already established partnerships with global financial institutions, offering a scalable and secure way for investors to participate in the RWA market. Its platform is designed for both retail and institutional investors, making it a key player in the future of decentralized finance. By integrating RWAs into its ecosystem, BOM Network aims to drive the mainstream adoption of blockchain technology and create a more efficient, liquid, and globally accessible financial system.
As the tokenization of RWAs gains traction, projects like BOM Network are leading the charge toward a more stable, diversified, and globally inclusive crypto market.
About BOM Network
BOM is the perfect bridge for capital from the real world to the Blockchain world. Meet a huge supply and demand of borrowing and lending from the real world into the cryptocurrency market. RWAs are likely to accelerate institutional adoption of blockchain technology. Moreover, the introduction of RWAs will catalyze regulatory development as governments and financial authorities adapt to this new intersection of traditional assets and blockchain technology. This convergence will bring crypto further into the mainstream, providing a fertile ground for innovation and growth.
Social Links
X: https://x.com/BOM_Network
Telegram: https://t.me/BOMNetworkCommunity
YouTube: https://www.youtube.com/@bom_network
Media Contact
Brand: BOM Network
Contact: Media contact
Email: support@bomnetwork.io
Website: https://bomnetwork.io
The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith.
Sectors: Top Story, Corporate News
SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...
MALANG, E. JAVA, Indonesia, Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) - Brawijaya University collaborated with several international institutions to develop the Magnetic Data Acquisition System (MAGDAS) to monitor climate change globally and mitigate disasters in the future.Disaster mitigation and natural resource exploration expert from Brawijaya University, Prof. Sukir Maryanto, in the MAGDAS Cangar Station in East Java. (ANTARA/HO-Brawijaya University)Some institutions partaking in this initiative include the International Research Center for Space and Planetary Environmental Science (i-SPES) from Kyushu University in Japan, the National Research Institute of Astronomy and Geophysics (NRIAG) of Egypt, and several universities in Malaysia.Disaster mitigation and natural resource exploration expert from Brawijaya University, Prof. Sukir Maryanto, explained that one of the data system stations is located in the Volcano & Geothermal field laboratory in the Agro Techno Park Cangar Complex, Sumberbrantas Village, Batu City, East Java."It will be developed to mitigate tectonic and volcanic earthquake disasters," he noted in a statement on Thursday (Dec 5).Construction for the Cangar Station, which is the collaboration between BRAVO GRC, Brawijaya University, and i-SPES Kyushu University, began in March 2024.The installation of this data system involved a team from Kyushu University and two scientists from Egypt, with one acting as a researcher at i-SPES and the other a partner from the NRIAG in Egypt.Later, after becoming fully functional, the MAGDAS in Cangar Station will be integrated with a system network centered at Kyushu University, Japan, Prof. Sukir added."The construction of the MAGDAS station in Cangar has a significant impact on research and collaboration both at the national and international levels," he remarked.The plan is that in March 2025, an induction-based magnetometer sensor developed by Nagoya City University, Japan, will be installed on the recommendation of the MAGDAS host at Kyushu University.Currently, two new devices have been installed at Cangar Station, including the 3D Fluxgate Magnetometer from i-SPES Kyushu University and a seismic sensor from BRAVO GRC Brawijaya University.The seismic sensor functions to detect seismic waves that occur on Earth.Prof. Sukir expressed hope that these two parameters can be studied in an integrated manner at Cangar Station so that science can be developed to connect phenomena on Earth and in space."The new magnetometer sensor will be installed side by side with the existing MAGDAS and seismic sensors," he explained."Data from magnetic and seismic sensors need to be studied intensively because phenomena on the ground and phenomena in the air are not necessarily the same," he pointed out.Sukir also showed real-time recordings from MAGDAS in Cangar, which include data from Peru, Japan, the Philippines, and Malaysia, as well as various magnetic components with different variations.For more information, please click: https://ub.ac.idBrawijaya University: https://prasetya.ub.ac.id Editor: Yuni Arisandy Sinaga, Copyright (c) ANTARA 2024 Copyright 2024 ACN Newswire via SeaPRwire.com.
HONG KONG, Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) – As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by robust R&D capabilities and exceptional commercialization expertise.Breakthroughs in Renal Disease Innovation with EVER001On December 4, Everest Medicines announced positive results in preliminary analysis of Phase 1b/2a clinical trial of EVER001, its next-generation, globally owned covalent reversible Bruton’s Tyrosine Kinase (BTK) inhibitor. The trial focuses on primary membranous nephropathy (pMN), a common pathological type of nephrotic syndrome in adults with significant unmet medical needs. The prevalence of pMN in China has been increasing, making it the second most common cause of nephrotic syndrome after IgA nephropathy (IgAN). Currently, there are approximately 2 million patients with pMN in China, 80,000 to 100,000 in the United States, 80,000 in Europe, and 40,000 in Japan,with incidence rates rising in recent years, reflecting its growing global disease burden.Unlike traditional covalent irreversible BTK inhibitors, EVER001 employs a novel covalent reversible mechanism that combines strong target binding with excellent selectivity, significantly reducing off-target toxicity. Positive results in preliminary analysis revealed promising outcomes, with over 90% reductions in anti-PLA2R antibodies and substantial improvements in proteinuria. Additionally, patients in the low-dose cohort who have completed 36 weeks of treatment, 81.8% achieved overall clinical remission, and 91% achieved immunological complete remission. In the high dose cohort, 85.7% patients achieved overall clinical remission and all patients achieved immunological complete remission by week 24. With no currently approved treatments for pMN, EVER001 represents a potentially best-in-class therapeutic candidate. These results highlight EVER001’s potential to deliver best-in-class efficacy and safety, making it a promising treatment not only for pMN but also for a range of other autoimmune glomerular diseases, including lupus nephritis (LN), IgAN, Minimal Change Disease (MCD), and focal segmental glomerulosclerosis (FSGS).With broad indication potential, rising disease prevalence, and Everest Medicines’ global rights, EVER001 represents a high-value asset in a “Blue Ocean” area with significant commercial potential. Kidney disease therapeutics have become a hotspot for innovation and investment in recent years, attracting major multinational pharmaceutical companies. For example, Vertex Pharmaceuticals acquired Alpine Immune Sciences this April for $4.9 billion to access its kidney autoimmune disease therapies. Similarly, Novartis acquired Chinook Therapeutics in June 2023 for $3.5 billion, gaining access to two late-stage treatments for rare, severe chronic kidney diseases.Driving Commercial Success with a Dual-Engine StrategyEverest Medicines continues to strengthen its leadership in nephrology with NEFECON(R), the first FDA-approved treatment for IgAN and the first etiological therapy for IgAN in China. Its inclusion in the 2024 National Reimbursement Drug List (NRDL) marks a significant milestone, enhancing patient accessibility and driving market penetration starting January 1, 2025. Since its commercial launch in May 2024, NEFECON(R) has generated RMB167 million in sales within its first month. The product is also approved in Macau, Hong Kong, Taiwan, South Korea, and Singapore, further cementing Everest’s expertise in nephrology.Everest’s diversified portfolio also includes XERAVA(R) and VELSIPITY(R). XERAVA(R), a novel broad-spectrum antibiotic, demonstrated an overall effectiveness rate of 90.9% after three days of treatment in the "Comprehensive Evaluation Project on the Clinical Application of Eravacycline", contributing RMB134 million in revenue in H1 2024. VELSIPITY(R), approved under the "Hong Kong and Macau Medicine and Equipment Connect" policy, is now available in three designated medical institutions within the Greater Bay Area. It has also received approvals in Macau and Singapore, with an NDA accepted in Hong Kong and plans for an NDA submission in Mainland China by year-end.Everest is accelerating innovation through its proprietary mRNA platform, a cornerstone of its long-term R&D strategy. In August 2024, Everest launched an Investigator-Initiated Clinical Trial for EVM16, a personalized mRNA cancer vaccine, at Peking University Cancer Hospital and Fudan University Cancer Hospital. The company is also advancing mRNA-based in vivo CAR-T programs for cancer and autoimmune diseases, expanding its pipeline’s potential.As of now, Everest Medicines reached a 52-week high of HKD 49.7, closing at HKD 47.85. Since announcing its mid-year results, the stock price has more than doubled, reflecting strong investor confidence. With its dual-engine strategy, Everest has positioned itself as a rising leader in the global biopharmaceutical industry, focusing on unmet medical needs, particularly in renal diseases, and breakthrough therapies like EVER001. Supported by strong financial momentum and a clear vision, Everest is poised for sustainable growth and lasting value for patients and shareholders. Copyright 2024 ACN Newswire via SeaPRwire.com.
TOKYO, Dec 11, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad) from the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia.This approval is based on the results of a multicenter, active-controlled, double-blind, parallel-group, randomized, Phase 3 study conducted by Eisai in China.1 In this study, 451 gout patients were randomized into either the dotinurad group or febuxostat group in a 1:1 ratio. The results of this study showed that the proportion of subjects with serum uric acid levels of 6.0 mg/dL or less at 24 weeks, which was the primary endpoint, was 73.6% [95% confidence interval (CI): 67.8, 79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the febuxostat group, confirming the statistical superiority of dotinurad 4 mg over febuxostat 40 mg (difference of proportion 35.87% [95% CI: 27.36, 44.37, p<0.001]).The most common adverse events were gouty arthritis, COVID-19, and liver function abnormality in the dotinurad group, and gouty arthritis, COVID-19, and increased alanine aminotransferase (ALT) in the febuxostat group. No new safety concerns with dotinurad were observed.“URECE” is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate transporter (URAT1) related to reabsorption of uric acid in the kidney. Eisai concluded a license agreement with FUJI YAKUHIN for China and five ASEAN member states: Indonesia, Malaysia, Myanmar, the Philippines, and Thailand, granting exclusive development and distribution rights in these countries. URECE was approved in Thailand for gout and hyperuicemia in September, 2024. In Japan, FUJI YAKUHIN obtained manufacturing and marketing approval for URECE in January 2020 and launched it in May 2020.It is estimated that there are currently about 16 million patients with gout in China.2 It is expected that the number of patients will further increase in the near future due to changes in lifestyle and dietary preferences in accordance with socioeconomic development.Eisai is committed to providing “URECE” to more patients with gout in China, including through its inclusion in the National Reimbursement Drug List (NRDL), and will contribute to improving the quality of life (QOL) of patients.“优乐思®” Product OutlineChinese Trade name: “优乐思” (URECE)Chinese generic name: 多替诺雷片 (Dotinurad Tablets)Indication for use: It is indicated for gout patients with hyperuricemia.Dosage and administration: For oral use, the usual adult initial dosage is 1 mg of dotinurad once daily. The dose level should then be gradually increased as needed by checking blood uric acid levels. The usual maintenance dosage is 2 mg once daily and may be adjusted according to the patient’s condition, but up to 4 mg once daily.About “URECE®” (Dotinurad)URECE is a therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. URECE selectively inhibits URAT1, one of the uric acid transporters, thus preventing reabsorption of uric acid by the kidneys and promoting uric acid excretion in the urine. In addition, URECE has a small effect on other transporters affecting uric acid secretion, so it reduces serum uric acid levels at lower doses. URECE is expected to have a low risk of side effects and drug interactions.In Japan, FUJI YAKUHIN obtained manufacturing and marketing approval for URECE in January 2020 and launched it in May 2020.About the Phase 3 Clinical Trial (Study FYU-981-J086-301)1This was a multicenter, active-controlled, double-blind, parallel-group, randomized, Phase 3 study conducted to confirm the superiority of dotinurad 4mg over febuxostat 40mg as the primary evaluation, assess safety, and confirm the non- inferiority of dotinurad 2mg to febuxostat 40mg as the secondary evaluation in Chinese patients with gout.Patients with gout and serum uric acid (SUA) levels exceeding 7.0 mg/dL were randomly assigned to either the dotinurad group or the febuxostat group in a 1:1 ratio, investigational product treatment for 24 weeks (the dotinurad group received 1mg/day for 4 weeks, 2mg/day for 8 weeks, and 4mg/day for 12 weeks, while the febuxostat group received 20mg/day for 4 weeks and 40mg/day for 20 weeks). The primary endpoint was the proportion of patients with SUA ≤6.0mg/dL at 24 weeks, and the secondary endpoint was the proportion of patients with SUA ≤6.0mg/dL at 12 weeks.Of the total 451 patients, 225 were assigned to the dotinurad group and 226 to the febuxostat group. Of these, 441 patients (220 in the dotinurad group and 221 in the febuxostat group) were included in the Full Analysis Set (FAS).For the primary endpoint, the proportion of patients with SUA ≤6.0mg/dL at 24 weeks was 73.6% [95% confidence interval (CI): 67.8, 79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the febuxostat group, confirming the statistical superiority of dotinurad 4mg over febuxostat 40mg (difference of proportion 35.87% [95% CI: 27.36, 44.37, p<0.001]).For the secondary endpoint, the proportion of patients with SUA ≤6.0mg/dL at 12 weeks was 55.5% in the dotinurad group and 50.5% in the febuxostat group, confirming the statistical non-inferiority of dotinurad 2mg to febuxostat 40mg (difference of proportion 5.24% [95% CI: -3.69, 14.17]).The most common adverse events were gouty arthritis, COVID-19, and liver function abnormality in the dotinurad group, and gouty arthritis, COVID-19, and increased alanine aminotransferase (ALT) in the febuxostat group. No new safety concerns with dotinurad were observed.(1) Sun J, Wang Y, Zhang X, et al. POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY COMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESE SUBJECTS. Annals of the Rheumatic Diseases 2024;83:407-408.(2) For the estimated data regarding the number of patients with gout: Data of morbidity prevalence rate - Rui Liu et al., Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis, BioMed Research International, Volume 2015, Article ID 762820Estimated data calculated from United Nations World Population Estimates - World Population Prospects, URL:https://population.un.org/wpp/ Media Inquiries:Eisai Co., Ltd.Public Relations Department TEL: +81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.
TOKYO, Dec 10, 2024 - (JCN Newswire via SeaPRwire.com) - The Association for Promotion of Sustainable Finance Platform (AP-SFPF) and Hitachi, Ltd. (Hitachi) today announced that we will begin providing the first template feature adapted to the IFRS sustainability disclosure standards in Japan (IFRS S1 and S2*1) formulated by the International Sustainability Standards Board (ISSB), on the Sustainable Finance Platform - Engagement Support Service (SFP-ESS), a digital platform that promotes ESG investing by establishing seamless connections between asset management companies and listed companies.Specifically, Hitachi's SFP-ESS, developed under license from the IFRS Foundation, will be enhanced with a templatedesigned to facilitate reporting in accordance with IFRS S1 and S2 and the SASB Standards*2 (Templates). AP-SFPF will offer the Templates to asset management companies and listed companies in Japan as the service provider.By starting to provide the Templates, AP-SFPF and Hitachi will support listed companies in Japan in their disclosure of information in conformance with IFRS S1 and S2 and communication between listed companies and assetmanagement companies. This will enable global institutional investors to properly evaluate sustainability-conscious corporate activities in the ESG perspective and contribute to the enhancement of the companies' corporate value.AP-SFPF is a general incorporated association that was established to connect diverse stakeholders andpromote effective and efficient communication, solving issues and considering projects to contribute to the continued development of the ESG market. It was established in July 2023 by eight companies, which mainly include financial institutions: MS&AD Insurance Group Holdings, Inc., Sompo Japan Insurance Inc., Tokio Marine & Nichido Fire Insurance Co., Ltd., Nippon Life Insurance Company, Hitachi, Ltd., Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation, and MUFG Bank, Ltd.Background of the start to adapt the SFP-ESS for IFRS S1 and S2Recently, investors' interest in companies' sustainability initiatives has been growing and companies are implementing sustainability initiatives and disclosing information about them. However, there are various disclosure standards in Japan and global. This has created an issue regarding disclosures. The people in charge of disclosing information,especially people at listed companies engaging in business globally, are not sure which standards to refer to and unable to determine investors' expectations regarding the disclosure of information, in addition to being short of resources. To solve this situation, the ISSB announced IFRS S1 and S2 in June 2023 as global baseline standards forthe disclosure of sustainability-related information.In Japan, the Sustainability Standards Board of Japan (SSBJ) is formulating the Japanese version of S1 and S2 (the SSBJ standards), which are made to comply with all of the requirements of IFRS S1 and S2, the standards fordisclosing sustainability-related informationin Japan. The finalized standards are planned to be published by March 2025. In addition, the Financial ServicesAgency made it mandatory to disclose sustainability-related information in securities reports in the fiscal year ended March 31, 2023. It is also considering the gradual application of the SSBJ standards to companies listed on the PrimeMarket starting in the fiscal year ending March 31, 2027. Therefore, listed companies are facing urgent tasks, such asthe collection of sustainability-related information and the development of a disclosure process in line with IFRS S1and S2, to prepare for the disclosure of information becoming mandatory in the future and to enhance their corporate value.In response, AP-SFPF exchanged opinions with more than 100 companies, including asset management companiesand listed companies, and began to offer a beta version of the SFP- ESS and verify its value in October 2023 to reduce the workload of the people at listed companies in charge of disclosing information and promote ESG investingin Japan. By using the Templates to adapt the SFP-ESS to IFRS S1 and S2, AP-SFPF and Hitachi will help listed companies smoothly disclose ESG information and contribute to improving their corporate value.Outline of SFP-ESSThe SFP-ESS is a two-sided platform on which asset management companies and listed companies making ESG investments are connected seamlessly to deepen their mutual understanding of each other. Asset managementcompanies present their needs regarding the ESG information it expected that listed companies disclose in line with theSASB*2 Standards. Listed companies refer to this registered information, which enables them to understand the needs of asset management companies and use the information when formulating their disclosure policies.Listed companies enter their data into the platform and send it, publishing it alongside comments by following the disclosure items in the Templates. This facilitates asset management companies' side-by-side comparison of listedcompanies as the viewers and also enables them to understand data, including the details.Features of the Templates adapted to IFRS S1 and S2Regarding IFRS S1 and S2, documents explaining the disclosure standards themselves, the IFRS Sustainability Disclosure Taxonomy*3, and support materials including a guide for the voluntary application of ISSB Standards havebeen published. However, Japanese documents are limited, and each company is left to decide how they will disclose the information they should disclose in their integrated reports and other reports. To support the practical tasks done by these listed companies, the Templates come with an input interface available in Japanese, so that digital data can be entered and saved on the platform in accordance with definitions in the taxonomy. Specifically, the Templates helplisted companies understand and respond to IFRS S1 and S2 using the following three features.1. Disclosure items classified into three categories (major categories, intermediate categories, and subcategories)The IFRS Sustainability Disclosure Taxonomy information is classified in detail into four core classifications (governance, strategy, risk management, and metrics and targets). However, the hierarchical structure differs from item to item. In response, a creative measure was devised to streamline data entry by the people in charge ofthe disclosure of information at listed companies by classifying the information into major categories,intermediate categories and subcategories visualizing the hierarchical structure of the information. This helps the people in charge of disclosing information at companies understand information collection based on the definitions in IFRS S1 and S2 without difficulty.2. Supplementary information from the IFRS Foundation regarding each disclosure item is provided when viewing the Templates.The IFRS Foundation, provides application guidance which companies may want to refer to when entering information into the Templates.3. Tables styles and options enabling an intuitive understanding of the information that needs to be disclosed are availableOptimal table styles are provided on an item-by-item basis to enable people to intuitively understand and enter the information required for each disclosure item. For example, there is an appropriate answer space for itemsthat are yes or no questions. In addition, for items which require that risks be described, there is a multiple-choice section about the type of risk (physical or transition) and the time frame (short, medium, or long term), in addition to the space for describing the risk. This prevent the omission of information or the provision of insufficient information.Future developmentMoving forward, AP-SFPF and Hitachi will broadly expand the SFP-ESS with the Templates to listed companies andtalk with multiple listed companies preparing to comply with IFRS S1 and S2 ahead of others. It will thus collect opinionsand requests regarding the improvement of the convenience of the Templates and develop the Templates so that we are more useful and adapted to IFRS S1 and S2.We will also work to functionally enhance the SFP-ESS in addition to developing the Templates. Specifically, they moveforward with consideration and development to provide service features which will be needed in the promotion ofthe disclosure of information, dialogue, and engagement between asset management companies and listedcompanies, such as a feature enabling asset management companies to register their information disclosure needs, and to release these features one by one. We also plan to incorporate the finalized SSBJ standards which will be published by the SSBJ by March 2025.Speaking at Director of Earned Revenue, IFRS Sustainability, Eli Reisman, said:“The IFRS Foundation welcomes Hitachi as a licensee of its standards. The IFRS Foundation encourages companiesvoluntarily applying IFRS S1 and IFRS S2, in addition to the progress being made towards regulatory adoption or other use of IFRS S1 and IFRS S2 happening in 25+ jurisdictions globally. In order to facilitate this corporate disclosure, it’s imperative that various services and tools integrate the ISSB standards to support this process."Yasuki Imai, Vice President and Executive Officer, Head of Digital Systems & Services APAC Business, and CEO of Financial Institutions Business Unit, Hitachi, Ltd, said:“In line with this approach to sustainability reporting, Hitachi and its only reseller of SFP-ESS, The Association forPromotion of Sustainable Finance Platform, aim to facilitate the application of IFRS S1, S2, and SASB standards and provide guidance on industry-specific disclosures through the SFP-ESS platform: SFP-ESS is a digital platformdesigned to support companies in their sustainability reporting efforts. This tool is intended to assist companies in navigating the reporting process, with the goal of enhancing the standardization and relevance of ESG reporting.”AP-SFPF member company, Managing Executive Officer, Group Chief Sustainability Officer (CSuO), MS&AD Insurance Group Holdings, Inc., Naomi Motojima said:“MS&AD Insurance Group Holdings, Inc. engages in investment, lending and insurance underwriting activities in consideration with ESG as a signatory to Principles for Sustainable Insurance (PSI) and the Principles for ResponsibleInvestment (PRI). We consider “Symbiosis with global environment ~Planetary Health~” as an important issue forMS&AD group, and we are working on realizing “Action on climate change” and “Improvement of sustainability of natural capital” comprehensively to enhance the resilience of society. We help to solve ESG issues including climate change through insurance underwriting, investment and lending, and of course we also work to reduce our own Greenhouse gas (GHG) emissions. We regard them as missions that we have as an insurance and financing serviceprovider. SFP-ESS is a platform that increases the mutual understanding of companies and financial institutions regarding ESG information disclosure. We hope that using the disclosure templates adapted to S1 and S2, which will be newly implemented, will facilitate the disclosure of information related to companies' ESG activities and lead to investors appropriately evaluating the companies. Further, from the standpoint of an investor, we find the developmentof a platform which enables users to compare the information disclosed by companies using a same index beneficial in the activities for the appropriate evaluation of the activities of the companies. Therefore, we welcome the release of the template feature.”*1 Disclosure standards announced by the IFRS Foundation in June 2023. The standards consist of IFRS S1 (General Requirements for Disclosure of Sustainability-related Financial Information) and IFRS S2 (Climate-related Disclosures).*2 The Sustainability Accounting Standards Board (SASB) Standards provide industry-specific ESG disclosure guidance focused on financial materiality. As of August 2022, the International Sustainability Standards Board (ISSB) of the IFRS Foundation assumed responsibility for the SASB Standards.*3 The IFRS Sustainability Disclosure Taxonomy is a framework for digitally tagging sustainability-related financial disclosures Its goal is to digitalize informationand facilitate investors' and stakeholders' comparison and assessment of companies' sustainability performanceSFP-ESS websitehttps://sfp-ess.org/en/service/About the Association for Promotion of Sustainable Finance Platform (AP-SFPF)The AP-SFPF was established in July 2023 to solve issues and consider projects, with financial institutions playing a leading role, to create new value and contribute to the continued development of the ESG market, eventually resultingin the sustainable development of society through the connection of various stakeholders to each other and the provision of a platform which will facilitate efficient and effective communication related to ESG issues.Member companies: MS&AD Insurance Group Holdings, Inc., Sompo Japan Insurance Inc., Tokio Marine & NichidoFire Insurance Co., Ltd., Nippon Life Insurance Company., Hitachi, Ltd., Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation., MUFG Bank, Ltd.Representative: Yoshihiro Kanaoka, Representative Director Location: 1-6-1 Marunouchi,Chiyoda-ku, Tokyo 100-8220, Japan Corporate website: https://sfp-ess.org/en/About Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railway systems, and “Connective Industries” – connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company's website at www.hitachi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
The four-day “Asia Pacific Food Expo 2024” successfully concluded on Monday (Dec 9th), with over 50 business matching negotiations taking place at the Macao Pavilion. Macao exhibitors are satisfied with the outcomes, as “Made in Macao” and “Macao Brand” products have garnered substantial repurchases and inquiries. “Sales figures for a single day at the event surpass those typically seen in Macao on weekdays”. The heightened demand at the event has elevated the popularity of Macao products to a peak, establishing them as the preferred choice among Singaporean and international businessmen. Moreover, some exhibitors have successfully connected with the local supermarkets and food agents through interactions. Furthermore, some businessmen have shown optimism regarding Macao’s business environment and the significant potential of Halal catering market in general. They engaged in profound discussions with Macao enterprises on-site and expressed their intentions to establish a presence in Macao.
In Singapore, Ms. Elaine Wong, Member of Board of Directors of Macao Commerce and Investment Promotion Institute (IPIM), met with Honorary President Edward Liu and Executive Director Jan Tan of the Asian Federation of Exhibition and Convention Associations (AFECA) to promote the MICE advantages of Macao and Hengqin, and invited AFECA to hold conventions and exhibitions in Macao and Hengqin. Mr. Edward Liu expressed his intention to visit Macao and Hengqin for an inspection tour in 2025. Established in Singapore in 2005, AFECA currently has about 155 members, which are mainly the MICE industry associations in Asia.
The “Consumption + Negotiation” Integrated Exhibition Aids Enterprises in Connecting with International Business Opportunities
Organised by the Singapore Food Manufacturers’ Association, the “Asia Pacific Food Expo 2024” has an exhibition area of about 10,000 square meters. The event has drawn the participation of over 200 exhibitors from mainland China and Singapore, encompassing upstream, midstream and downstream industrial chain enterprises in the food and beverage industries. IPIM and the Industrial Association of Macau set up the Macao Pavilion, for the first time, at the “Asia Pacific Food Expo”, and organised the participation of 24 Macao SMEs and over 250 “Made in Macao”, “Macao Brand” products, of which nearly 80% were Halal-certified products or the distinguished “M Brand” quality products.
Throughout the four-day event, Macao exhibitors, and the buyers and visitors from around the globe all benefited significantly. According to the Macao enterprises, the diverse customer sources of the Expo enable them to swiftly comprehend and access the latest market trends, and to grasp the new consumption patterns of international customers. Furthermore, the “consumption + negotiation” integrated exhibition can function as a platform for testing the products and establishing business networks. Local Internet influencers were also invited to promote Macao companies’ brands and their charms at the Macao Pavilion.
Leveraging Insights from the Global Halal Food Sector to Craft the Golden Business Card for Halal Food in Macao
At the event, exhibitors were delighted to witness the positive reception of Macao’s halal food by the visitors. Through the exhibition, they have recognised significant business prospects in Singapore and other halal food markets. They will leverage insights from the Singapore’s Halal food to upgrade Macao’s halal food production, in order to further enrich the experience of international visitors to Macao, thereby crafting Macao’s golden business card.
Some visitors praised the layout and arrangement of the Macao Pavilion, which could let them fully feel the charm of Macao and quickly grasp the latest business information of Macao and Hengqin. The accurate connection with Macao enterprises for “one-on-one” negotiations also strengthened their intention to invest in Macao and Hengqin.
一连四天的“亚太国际食品展2024”于今(9)日圆满闭幕。澳门馆内促逾50场配对洽谈,展商们满意成效,“澳门制造”、“澳门品牌”的产品获得高回购及高查询,“单日货品销量至少是澳门平日的翻倍”,连日热销让澳门产品的知名度推至高点,成为新加坡以至国际客商的“心头好”;亦有展商成功连线当地商超、代理商等。此外,有与会客商看好澳门营商环境以及清真市场发展潜力庞大,即场与澳门企业开展深入交流,并有落户澳门计划。
赴新加坡期间,澳门特别行政区招商投资促进局委员黄伊琳会面亚洲展览会议协会联盟(AFECA)Honorary President Edward Liu及Executive Director Jan Tan,推介澳琴会展优势,亦诚邀该会赴澳琴办展办会。Edward Liu透露2025年有计划赴澳琴考察。AFECA于2005年在新加坡成立,现有会员单位约155个,主要来自亚洲地区的会展行业协会。
“消费+洽商”一体展会助企业联通国际商机
“亚太国际食品展2024”由新加坡食品厂商联合会主办,展览面积约一万平方米,吸引来自中国内地、新加坡等逾200家展商参与,涵盖食品及饮料等行业的上中下游产业链企业。招商投资促进局联同澳门厂商联合会首次设置澳门馆,组织24家澳门中小企展销展示250多款“澳门制造”、“澳门品牌”产品,当中近80%澳门展商产品持清真认证或及“M唛”澳门产品优质认证。
四天展会澳门展商及世界各地与会客商均收获满满。有澳门企业代表指该展会客源多样,有助快速了解及获取市场最新动态,掌握客群的新型消费模式,而且展会集消费及洽商为一体,成为企业视作产品“试水”和建立商业网络的绝佳平台。澳门馆内还安排了当地的网络达人穿梭走访展位,助企业宣传推广品牌及产品魅力。
取经各地清真食品之长打造澳门清真食品新名片
同时展商喜见澳门清真食品获得不少客商好评,通过实地参展,了解到新加坡等清真食品市场商机巨大,会借镜新加坡清真等食品优点,融入到澳门清真食品升级箇中“内涵”,进一步满足并丰富国际客商的游澳体验,继而“升呢”成为澳门新名片。
有与会客商点赞展馆布局及安排到位,充分感受到澳门魅力的同时,亦能快速掌握澳琴最新营商信息,并叠加精准对接澳门企业开展“一对一”洽谈,加强了在澳琴投资的意欲。
TOKYO, Dec 11, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited, Toyo University Incorporated Educational Institution (Toyo University) and Kokoro Balance Research Institute today announced the commencement of a field trial on December 3, 2024, to develop a Training Program for Coping with Customer Aggression. This program leverages AI and incorporates insights from criminal psychology and mental health to tackle the growing societal issue of customer harassment, i.e., unreasonable or abusive behavior directed at staff by customers and clients.The program utilizes the “AI Tool for Experiencing Customer Aggression” developed using Fujitsu's generative AI technology, behavior change support technologies and Toyo University's expertise in criminal psychology. Fujitsu’s AI tool provides interactive feedback through the use of AI avatars and clarifies actions that can be taken to enhance participants' customer harassment response skills. To evaluate the program's effectiveness, Kokoro Balance Research Institute will leverage its mental health expertise to develop new psychological scales measuring customer service skills, stress management, and overall customer harassment response capabilities. Furthermore, the research partners will carry out a field trial with call center employees at Fujitsu Communication Services Limited (CSL), analyzing changes in participants' customer service skills, stress management, engagement, and subjective productivity to ensure the program's scientific validity.The full program is targeted for launch in fiscal 2025 with the goals of reducing the psychological burden of working people in customer service roles and contributing to the creation of safe and supportive work environments.BackgroundCustomer harassment has become a serious social issue. A recent survey revealed that 46.8% of service industry workers have encountered customer harassment in the past two years, with nearly half experiencing lasting physical and mental health consequences.In response, the Ministry of Health, Labour and Welfare added mental health issues related to customer harassment to its work-related injury recognition criteria in September 2023. Furthermore, the Tokyo Metropolitan Assembly passed Japan's first customer harassment prevention ordinance in October 2024. The growing national and local government efforts are driving increased organizational responsibility for employee protection.Field Trial PeriodDecember 3, 2024 to March 31, 2025Figure 1: Overview diagram of the field trial Comment from Akiko Yamada, Head of the Converging Technologies Laboratory of Fujitsu Research, Fujitsu Limited:We have been pursuing research in converging technologies, combining cutting-edge digital technology with knowledge from humanities and social sciences to solve various social issues. This new initiative combines generative AI, behavioral change support technology, criminal psychology, and mental health expertise to tackle the significant social problem of customer harassment and secure the well-being of working people.Comment from Prof. Masayuki Kiriu, Dean, Faculty of Sociology, Toyo University:By incorporating psychological scales and stress measurement indicators into the "AI Tool for Experiencing Customer Aggression”, we expect to create a practical and effective customer harassment response training program for customer service personnel. This will significantly contribute to solving current customer harassment issues. We anticipate the emergence of new social contributions through converging technology in this pilot program.Comment from Kyoko Shimada, Representative Director, Kokoro Balance Research Institute:Customer harassment can inflict deep emotional wounds on employees. While eradication may be impossible, we can reduce its impact through organizational efforts. This research aims to strengthen organizations by focusing on employee mental health and response capabilities. By using globally recognized psychological scales and effective evaluation criteria, we aim to make this program scientifically sound, useful, and applicable for employees.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiriesToyo UniversityToyo University General Affairs Department, Public Relations DivisionPhone: 03-3945-7571Reception hours: 9:00-18:00 JST (excluding Saturdays, Sundays, holidays, and university-designated holidays)E-mail: mlkoho@toyo.jpKokoro Balance Research InstituteE-mail: info@kokorobalance.jp Copyright 2024 JCN Newswire via SeaPRwire.com.
Nassau, the Bahamas , Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) - FxPro Group, a global leader in financial services and trading, has launched BankPro, a cutting-edge Private Digital Bank designed to redefine digital financial solutions for individuals and corporations. BankPro combines private banking services with advanced investment and trading capabilities, offering clients a seamless, all-in-one application tailored to their financial needs.The launch of BankPro underscores FxPro Group's commitment to innovation and excellence, leveraging its 25 years of expertise and $120 million in Tier 1 company capital to introduce a next-generation digital banking solution. BankPro is regulated by the Central Bank of The Bahamas and operates with the highest standards of security and compliance.Key Features of BankPro:Multi-Currency AccountsBankPro provides access to over 24 currencies, enabling effortless international transactions at competitive exchange rates. Clients can manage their finances globally with a single account designed for both personal and corporate use.Visa Platinum CardsClients can access exclusive Visa Platinum cards, offering customizable spending limits, global acceptance, and enhanced security. Additionally, instant virtual cards provide a secure and efficient solution for online transactions, making BankPro a versatile option for all financial activities.Global Banking with Flat FeesBankPro simplifies international banking with flat-fee structures, ensuring transparent and predictable costs. This approach is particularly advantageous for high-value transactions, providing clarity and value for clients engaged in global business and personal finance.Comprehensive Investment and Trading PlatformBankPro integrates investment and trading capabilities, allowing clients to manage and grow their portfolios within the same platform. Key features include:Investing in over 2,100 Stocks and ETFs: Clients gain access to major exchanges, including NYSE, Nasdaq, LSE, XETRA, and Euronext.Real-Time Market Data: Active subscriptions include free live pricing from Nasdaq and LSE.Through FxPro Global Markets Ltd., clients can also trade over 200 Derivatives across Forex, Commodities, Metals, Indices, Stocks, and ETFs, enabling portfolio diversification and risk management.Corporate Banking SolutionsBankPro offers tailored services for businesses, including multi-currency accounts, streamlined expense management tools, and advanced treasury management solutions. Corporate clients benefit from high-spending Visa Platinum cards, detailed reporting tools, and access to flexible investment options.A Strong Foundation in the BahamasBankPro operates from its state-of-the-art headquarters in Lyford Cay, Nassau. The facility reflects the company's commitment to The Bahamas as a central hub for its operations. The company also has an office in the City of London, UK.As a fully regulated entity, BankPro prioritizes security and reliability, holding a professional membership with the Association of International Banks and Trust Companies.The company's regulatory foundation ensures robust protection for clients, complemented by advanced digital onboarding tools and fraud prevention measures. These features, combined with the FxPro Group's legacy of excellence, make BankPro a trusted partner for financial services.About FxPro GroupWith 25 years of experience, the FxPro Group is a global leader in financial services, offering trading solutions across Forex, Commodities, and more. With a presence in over 170 countries and $200+ million invested in elite sponsorships, FxPro has earned over 120 industry awards for its innovative technology and reliable services.The launch of BankPro marks the Group's expansion into digital private banking, combining its expertise in trading with cutting-edge financial solutions designed for the modern client. To know more please contact +1 242 603 2226.Media ContactBrand: BankPro LimitedContact: Media teamWebsite: https://www.bankpro.com Copyright 2024 ACN Newswire via SeaPRwire.com.